These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2326881)

  • 1. Tolerance of cyclosporine oral capsules in a patient hypersensitive to standard oral and intravenous solutions of the drug.
    Cooney GF; Alpern JB; Narins BE; Goetz LK; Cavarocchi NC
    Transplantation; 1990 Apr; 49(4):823-4. PubMed ID: 2326881
    [No Abstract]   [Full Text] [Related]  

  • 2. Tolerance of cyclosporine oral capsules in a patient hypersensitive to standard oral and intravenous solutions of the drug.
    Cooney GF; Alpern JB; Narins BE; Goetz LK; Cavarocchi NC
    Clin Transpl; 1989; ():324. PubMed ID: 2487599
    [No Abstract]   [Full Text] [Related]  

  • 3. The absence of an allergic reaction to cyclosporine capsules in a patient allergic to standard oral and intravenous solutions of cyclosporine.
    van Hooff JP; Bessems P; Beuman GH; Leunissen KM
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):640. PubMed ID: 3363660
    [No Abstract]   [Full Text] [Related]  

  • 4. Absence of allergic reaction to cyclosporin capsules in patient allergic to standard oral and intravenous solution of cyclosporin.
    van Hooff JP; Bessems P; Beuman GH; Leunissen KM
    Lancet; 1987 Dec; 2(8573):1456. PubMed ID: 2892007
    [No Abstract]   [Full Text] [Related]  

  • 5. Intravenous cyclosporine for heart transplantation.
    Bolman RM; Cance CG
    Transplant Proc; 1989 Feb; 21(1 Pt 3):2488. PubMed ID: 2650312
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of the safety and efficacy of oral vs constant-rate intravenous infusion cyclosporine immediately following orthotopic heart transplantation.
    Myre SA; Schroeder TJ; Melvin DB; Pesce AJ; Collins JA; Stephens GW; First MR
    Transplant Proc; 1989 Feb; 21(1 Pt 3):2484-6. PubMed ID: 2650310
    [No Abstract]   [Full Text] [Related]  

  • 7. Covariables in cyclosporine immunosuppression.
    Grevel J; Napoli KL; Kahan BD
    Transplant Proc; 1990 Jun; 22(3):1113-5. PubMed ID: 2349671
    [No Abstract]   [Full Text] [Related]  

  • 8. Induction of unresponsiveness after local low-dose cyclosporine administration.
    Stepkowski S; Goto S; Reynolds K; Ito T; Kahan BD
    Transplant Proc; 1989 Feb; 21(1 Pt 1):1120-2. PubMed ID: 2650072
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of oral and intravenous cyclosporine A in kidney transplants.
    Asokan VS; Sweny P; Varghese Z; Moorhead JF; Fernando ON
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1717-8. PubMed ID: 3274412
    [No Abstract]   [Full Text] [Related]  

  • 10. Intravenous administration of cyclosporine for immunosuppression in heart transplant patients.
    Macris MP; Frazier OH; Van Buren CT; Lammermeier DE; Sweeney MS; Kahan BD
    Transplant Proc; 1989 Feb; 21(1 Pt 3):2487. PubMed ID: 2650311
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of the application form of cyclosporine on blood levels: comparison of oral solution and capsules.
    Nashan B; Bleck J; Wonigeit K; Vogt P; Christians U; Sewing KF; Beveridge T; Pichlmayr R
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):637-9. PubMed ID: 3284113
    [No Abstract]   [Full Text] [Related]  

  • 12. Intravenous cyclosporine to induce immunosuppression in cardiac allograft recipients.
    Macris MP; Frazier OH; Van Buren CT; Duncan JM
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):311-5. PubMed ID: 3291261
    [No Abstract]   [Full Text] [Related]  

  • 13. Cyclosporine absorption in two patients with short-bowel syndrome.
    Roberts R; Sketris IS; Abraham I; Givner ML; MacDonald AS
    Drug Intell Clin Pharm; 1988; 22(7-8):570-2. PubMed ID: 3416741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of cyclosporine by constant-rate intravenous infusion immediately after heart transplantation.
    Myre SA; Schroeder TJ; Melvin DB; Clardy CW; Pesce AJ; Wadhwa NK; Collins JA; Wolf RK; Brown LL; Stephens GW
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):316-22. PubMed ID: 3291262
    [No Abstract]   [Full Text] [Related]  

  • 15. Anaphylaxis to intravenous cyclosporine and tolerance to oral cyclosporine: case report and review.
    Volcheck GW; Van Dellen RG
    Ann Allergy Asthma Immunol; 1998 Feb; 80(2):159-63. PubMed ID: 9494448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Well-tolerated oral cyclosporine in a case of hypersensitivity to parenteral cyclosporine in postallogeneic bone marrow transplantation.
    Moeinian M; Sotoude H; Mohebbi Z; Asadollahi-Amin A; Mozafari R
    Indian J Pharmacol; 2018; 50(2):94-96. PubMed ID: 30100659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclosporine pharmacokinetics in the early course of renal transplantation.
    Albrecht K; Niebel W; Marggraf G; Eigler FW
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1719. PubMed ID: 3274413
    [No Abstract]   [Full Text] [Related]  

  • 18. Absorption kinetics of cyclosporine in healthy volunteers.
    Gupta SK; Benet LZ
    Biopharm Drug Dispos; 1989; 10(6):591-6. PubMed ID: 2611359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of cyclosporine for prevention of graft-versus-host disease after allogeneic bone marrow transplantation.
    Gluckman E; Devergie A; Lokiec F
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):461-9. PubMed ID: 3291282
    [No Abstract]   [Full Text] [Related]  

  • 20. Steady-state concentrations of cyclosporine for therapeutic monitoring.
    Grevel J; Napoli KL; Kahan BD
    Transplant Proc; 1990 Jun; 22(3):1339-42. PubMed ID: 2190397
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.